New research from the University of Liverpool has identified the role of a specific protein in the human body that can help prevent the survival and spread of eye cancer, by initiating cancer ‘cell-suicide’.
The new findings may help revolutionise the approach to metastatic uveal melanoma (UM) – a cancer that arises from the pigment cells (melanocytes) in the eye, and for which there is currently no effective treatment.
Metastasis is the spread of a cancer or other disease from one organ or part of the body to another without being directly connected with it. This occurs in about half of the patients with UM.
Although rare, UM is the most common primary eye cancer in adults. While the primary tumour can often be treated very effectively, up to 50% of patients develop metastases most often in the liver, for whom no effective therapy is available.
Programmed cell death
Apoptosis, or programmed cell death, is a rapid and irreversible process to efficiently eliminate dysfunctional cells. A hallmark of cancer is the ability of malignant cells to evade apoptosis.
Dr Luminita Paraoan, from the University’s Department of Eye and Vision Science in the Institute of Ageing and Chronic Disease, has published new findings in the British Journal of Cancer that identify the requirement of a protein called p63 for the initiation of apoptosis in UM.
Chromosome 3 is one of the 23 pairs of chromosomes in humans. People normally have two copies of each chromosome. One part of chromosome 3 contains the gene for the protein p63. Unfortunately people with aggressive (resistant to apoptosis) UM do not have this part and therefore do not have the p63 protein.
Dr Paraoan’s research found that if the p63 gene is used in combination with another gene, called p53, they can effectively target UM and start the process of apoptosis in the cancerous cells.
Tumour suppressor genes
The p53 gene is from a class of genes called tumour suppressors which are mutated in cases of cancer. Tumour suppressor genes are protective genes. Normally, they limit cell growth by monitoring how quickly cells divide into new cells, repairing damaged DNA, and controlling when a cell dies.
When a tumour suppressor gene is mutated, for example in cancer cases, cells grow uncontrollably and may eventually form a mass called a tumour. Therefore p53 itself is ineffective in starting the process of apoptosis of cancer calls in UM.
Of her research Dr Luminita said: “The study highlights for the first time the requirement of p63 in the initiation of apoptosis in UM”.
“Our findings have broad-ranging implications for other cancers in which apoptosis is evaded or is problematic. They will hopefully prove advantageous in designing therapeutic approaches to cancerous tumours that are currently resistant to chemotherapy and radiotherapy.”
Receive an email update when we add a new CANCER TREATMENT article.
The Latest on: Eye cancer treatment
via Google News
The Latest on: Eye cancer treatment
- Mom with aggressive cancer will likely lose eyesight, upper teeth during treatmenton November 13, 2019 at 7:55 am
A British mom of three diagnosed with aggressive cancer will likely lose her vision in one eye and her upper teeth to radiation therapy, a treatment she chose to undergo to spend more time with her ...
- New treatment offers dry eye reliefon November 13, 2019 at 6:37 am
The treatment is called Intense Pulsed Light (IPL ... “Then decreasing the inflammation to the eye will make the eye feel better.” (KFDX/KTJL) — For Lung Cancer Awareness Month in November, the ...
- Family and friends join forces at Blackpool school to raise money for childhood eye cancer charityon November 11, 2019 at 10:07 pm
They gave me a grant to help me with travel expenses, and they're always in Birmingham to support us when we're at the hospital there for Elsie's treatment. "I was so pleased the school agreed to help ...
- Eye on research: A new way to detect and study retinoblastomaon November 11, 2019 at 2:04 pm
Retinoblastoma is a cancer that forms in the light-detecting cells in the back of the eye. It often appears in children under two years of age and can lead to blindness or eye removal. Most cancers ...
- Mum's painful sacrifice for kids after cancer fears ignored by doctorson November 11, 2019 at 1:35 am
It wasn't until she had a biopsy six months later that a large cancerous tumour was spotted behind her nose and eye. She underwent surgery to remove it last month but there is a 50 per cent chance of ...
- Keep An Eye On ATNX, OCUL, SGMS…on November 11, 2019 at 12:08 am
Athenex is a biopharmaceutical company developing therapies for the treatment of cancer and related conditions. The company has an Oncology pipeline, a Commercial Platform, and a Global Supply Chain ...
- Mum with 'blocked nose' to lose sight and teeth in cancer fighton November 9, 2019 at 2:10 am
A mum will bravely undergo radiotherapy to treat her cancer even though she risks losing her upper teeth and sight in one eye. ALSO READ: Dietary changes that boost cancer treatment Kerry Borlase was ...
- Five Steps to a New Normal: Life After Canceron November 7, 2019 at 2:00 pm
Hearing the words “you have cancer” was devastating. It was a life-altering diagnosis that caused time to stand still. But once a plan was established and the treatment began, the fear and unknowns ...
- Are therapies for bladder cancer and macular degeneration compatible?on November 6, 2019 at 9:00 pm
the amount injected into the eye is approximately 0.1% of the amount that would be injected into the blood to treat colon cancer, for example. BCG (Bacille Calmette-Guerin) is a vaccine strain of ...
via Bing News